65-Medical Supplies-Potential Sources Sought. Military Treatment Facilities-(Army, Navy, Air Force and Marine Corps medical treatment facilities in Hawaii, Guam, Korea, Japan and Okinawa are in the process of standardizing Chlorhexidine Skin Prep D evices. Point of Contact: Susan Hwang, Team Leader/Logistician, Tri-Service Regional Business Office. TRICARE Pacific Region, Honolulu, Hawaii. Tel: (808) 433-3686. Potential sources sought to participate in the regional standardization of Chlorhexidin e Skin Prep Device. If your company holds or is in the process of obtaining a Distribution and Pricing Agreement (DAPA) with the Defense Supply Center Philadelphia (DSCP) for Chlorhexidine Skin Prep Devices your company is eligible to participate in the s tandardization process. This is in pursuant to the DAPA clause by which DAPA holders agree to the standardization process. Please respond by email to: susan.hwang@amedd.army.mil and provide your (1) company name, (2) address, (3) point of contact, (4) te lephone number, (5) fax number, (6) email address, and (7) complete answers to the below listed technical criteria no later than June 23, 2006. Send product literature on Chlorhexidine Skin Prep Device by June 23, 2006 to: Susan Hwang, Tri-Service Regiona l Business Office, Mail Code: MCHK-LDM, 1 Jarrett White Road, Tripler AMC, Hawaii 96859-5000. For questions, please call (808) 433-3686. Technical criteria for Chlorhexidine Skin Prep Device as follows: 1. Vendor has DAPA or is eligible for applying for a DAPA for hospital plastics. Provide DAPA number. 2. Vendor has distribution agreement with the Prime Vendor Cardinal Health. 3. Vendor will provide conversion Prime Vendor order numbers. 4. Vendor is able to supply the participating Military Treatment Facilities in Hawaii, Guam, Japan, Okinawa, and Korea. 5. Vendor is able to provide on-site support and in servicing to the entire Pacific Region. 6. Vendor offers educational resources and tools for clinical use of device, if applicable. 7. Vendor will provide MSDS information (if applicable). 8. Vendor will list the industry production and safety standards used in manufacturing this product. 9. Vendor will provide return goods policy. 10. Vendor will provide a history of backorders or recalls. 11. Vendor will provide name, phone number and e-mail address for vendor representative for the Pacific Region; and 1-800 number for Customer Service. 12. Vendor will provide latex free products 13. Vendor will itemize the brand(s) and styles that are manufactured and/or distributed. 14. Vendor will provide products which deliver 2% chlorhexidine gluconate (CHG) and 70% isopropyl alcohol. 15. Vendor will provide application products which rapidly activate against gram negative and gram positive bacteria. Please provide evidence. 16. Vendor will provide application products which prevent regrowth of microorganisms on the skin for at least 48 hours. Please provide evidence. 17. Vendor will provide application products which meet FDA criteria for a patient preoperative skin preparation antiseptic. Please provide evidence. 18. Vendor will provide application products which deliver solution that remains active in the presence of blood, serum, and other bioburden. Please provide evidence. 19. Vendor will provide a variety of sizes and shapes of application devices: (Please circle Yes or No) ? An ampoule device (crushable with cotton like wick for solution application) Yes No ? A small sponge like applicator with a handle or area to grasp device w/out contaminating device. Yes No ? Swab applicators. Yes No ? Sponge like applicator with handle and solution is in the handle. 3ml to 5ml solution delivered. Yes No ? Sponge like applicator with handle and solution is in the handle. 10 ml to 12 ml solution delivered. Yes No ? Sponge like applicator with handle and solution is in the handle. 20ml to 30ml solution delivered. Yes No 20. Vendor will provide both clear and tinted CHG with Isopropyl alcohol.